• Grail published findings from a Medicare fee-for-service analysis linking emergency department involvement at initial cancer diagnosis to higher first-year healthcare costs across cancer types.
• The study covered 818,120 beneficiaries with newly diagnosed invasive cancer from 2010-2020; 26.6% had ED involvement at diagnosis.
• Patients with ED involvement represented 39% of total all-cause healthcare costs in the year following diagnosis.
• Mean adjusted all-cause costs were USD 88,315 per patient for ED-diagnosed cases versus USD 62,813 for non-ED pathways, driven largely by acute inpatient hospitalization costs.
• Incremental first-year all-cause costs associated with ED involvement ranged from USD 6,409 for lung cancer to USD 104,862 for leukemia.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Grail Inc. published the original content used to generate this news brief on May 19, 2026, and is solely responsible for the information contained therein.